Aramark (NYSE: ARMK), the Philadelphia-based food services and facilities management company, carries a predominantly bullish Street view. Reviewing 12 recent, attributed targets yields a low-to-high range of $63 to $75.50 and a calculated mean of about $68.50, rounded to a central target of $68. Recent calls include UBS at $65 (cut from $71 on data-center ramp-timing concerns), Bank of America at $69, Morgan Stanley at $63 (Equal-Weight), Citigroup at $75.50, RBC Capital and Truist at $70, J.P. Morgan, Stifel, and Jefferies at $70, Baird at $69, and Oppenheimer and Deutsche Bank at $65.
The dispersion matters. The most cautious view ($63) assumes the Nexus data-center opportunity ramps more slowly, while the highest ($75.50) prices in faster, higher-multiple growth. This is a calculation of individual targets, not a published consensus, though independent data providers show comparable average figures near $68–$69. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock closed near $55.37 on Nov. 16, 2026, with a market value of roughly $14.6 billion and a 52-week range of $35.07 to $62.65. Reaching $68 requires about 23% upside — a substantial move given the shares already trade near their prior peak and well above the mid-2026 base. The path depends on execution: fiscal 2027 guidance calls for 9–10% organic revenue growth and 20–25% adjusted EPS growth, supported by a record $1.9 billion of annualized gross new business and roughly 97% client retention. If the data-center (Nexus) segment ramps as modeled, estimates could keep rising; if not, the stock may consolidate below its highs.
The shares' durable resistance level sits near the 52-week high around $62–$63, where the stock peaked in August 2026; clearing that zone would be a precondition for any sustained push toward $68. On the downside, support level around $50 aligns with the stock's recent post-earnings low, with the psychological $60 mark now acting as a key battleground. The broader uptrend from the $35 area remains intact, but the stock must absorb supply at prior highs before the higher targets become technically meaningful. I also checked this using Tickeron’s AI Real Time Patterns to confirm the key levels.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms' time frames can differ. Investors should watch quarterly organic-growth and retention figures, Nexus site signings and ramp milestones, margin progression against the 15–19% operating-income guide, and any further target revisions from firms such as UBS, Citigroup, and RBC Capital. Data-center capital-spending trends and broader food-services demand are also relevant to the market outlook.
In my own work, I find AI Daily Buy/Sell Signals particularly helpful for monitoring stocks like ARMK. It uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. The tool helps me scan for opportunities, keep an eye on existing positions, and spot changing trends more efficiently, serving as a useful supplement to fundamental analysis rather than a replacement.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ARMK moved above its 50-day moving average on November 16, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARMK's RSI Oscillator exited the oversold zone, 15 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Momentum Indicator moved above the 0 level on November 16, 2026. You may want to consider a long position or call options on ARMK as a result. In 67 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for ARMK just turned positive on November 11, 2026. Looking at past instances where ARMK's MACD turned positive, the stock continued to rise in 33 of 51 cases over the following month. The odds of a continued upward trend are 65%.
Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARMK advanced for three days, in 202 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
ARMK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARMK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
The Aroon Indicator for ARMK entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. ARMK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.081) is normal, around the industry mean (5.887). P/E Ratio (36.234) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.845) is also within normal values, averaging (1.946). Dividend Yield (0.009) settles around the average of (0.025) among similar stocks. P/S Ratio (0.776) is also within normal values, averaging (9.907).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company with interests in food services and facilities management
Industry OfficeEquipmentSupplies